Nephros, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 6/12/2017
Contact Info
  • 41 Grand Avenue
  • River Edge, NJ 07661

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001196298
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
  Blank Check
Incorporated In: DE, USA
Year of Inc. 1997
Employees 14 a/o Jun 12, 2017
Company Officers/Contacts
Daron Evans President, CEO
Andrew Astor CFO
Company Directors
Arthur Amron
Paul Mieyal Audit Committee Member
Malcom Persen Independent Director, Audit Committee Member
Moshe Pinto Independent Director
Service Providers
Accounting/Auditing Firm
Moody, Famiglietti, & Andronico
1 Highwood Drive
Tewksbury, MA, 01876
United States
Securities Counsel
Fredrikson & Byron, P.A.
200 S. Sixth St.
Suite 4000
Minneapolis, MN, 55402
United States
Investor Relations Firm
PCG Advisory Group
535 Fifth Avenue
24th Floor
New York, NY, 10017
United States
NEPH Security Details
Share Structure
Market Value1 $13,269,334 a/o Jun 23, 2017
Authorized Shares 90,000,000 a/o Sep 30, 2016
Outstanding Shares 54,160,547 a/o May 05, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 22,750,000 a/o Jun 01, 2017
Par Value 0.001
Shareholders of Record 64 a/o Mar 30, 2016
Short Selling Data
Short Interest 267,235 (9.96%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security